{"id":548559,"date":"2026-09-04T21:36:29","date_gmt":"2026-09-04T21:36:29","guid":{"rendered":"https:\/\/www.newjerseyheadlines.com\/news\/story\/548559\/quadropharma-announces-global-commercial-launch-of-immanx-mens-health-portfolio.html"},"modified":"2026-09-04T21:36:29","modified_gmt":"2026-09-04T21:36:29","slug":"quadropharma-announces-global-commercial-launch-of-immanx-mens-health-portfolio","status":"publish","type":"post","link":"http:\/\/www.northcarolinaheadlines.com\/news\/story\/548559\/quadropharma-announces-global-commercial-launch-of-immanx-mens-health-portfolio.html","title":{"rendered":"QuadroPharma Announces Global Commercial Launch of IMMANX Men’s Health Portfolio"},"content":{"rendered":"
Five specialist brands enter pharmacy, clinic, e-commerce and distribution channels with cGMP manufacturing and third-party testing <\/div>\n

NEW YORK, NY – September 4, 2026 – <\/strong>QuadroPharma<\/a>, also operating as Quadro Pharma Inc, announced the global commercial launch of IMMANX, its dedicated men’s health division comprising five specialist pharmaceutical and OTC nutraceutical brands focused on sexual confidence, performance, cognition, sleep and testosterone support.<\/p>\n

\"\"<\/p>\n

The IMMANX<\/a> launch brings together IMALPHAX, focused on sexual confidence; IMBOLDX, focused on performance; IMFOCUSX, focused on cognitive performance; IMSLEEPX, focused on sleep and recovery; and IMSTRONGX, focused on testosterone support.<\/p>\n

The IMMANX men’s health portfolio is now open for commercial partnerships across pharmacies, clinics, e-commerce platforms and national distribution networks internationally. The company is positioning the division within the growing markets for men’s health OTC, men’s nutraceuticals, men’s wellness brands, male health supplements, men’s performance supplements and OTC nutraceuticals.<\/p>\n

According to QuadroPharma, all five brands follow a common quality framework that includes cGMP manufacturing, independent third-party batch testing and health claims supported by citations to peer-reviewed research. The approach supports the company’s focus on pharmaceutical-grade nutraceuticals, cGMP certified supplements, third-party tested nutraceuticals, evidence-based men’s health, clinical nutraceuticals and research-supported product positioning. The attached company materials similarly identify cGMP manufacturing, third-party testing and peer-reviewed citations as the portfolio’s shared quality framework.<\/p>\n

“Men’s health has been chronically underfunded by the wellness shelf — not because demand doesn’t exist, but because no brand was willing to do the science first and the marketing second. IMMANX changes that. Every product in the portfolio is built to a pharmaceutical standard: cGMP manufacturing, third-party batch testing, and claims that cite journals, not influencers. We believe that rigour is the brand,” said Saif Quadri, CEO of QuadroPharma.<\/p>\n

Each brand addresses a different area within the broader men’s health portfolio. IMALPHAX addresses sexual confidence and the erectile health supplement category. IMBOLDX is positioned around men’s performance and sexual wellness. IMFOCUSX is designed as a cognitive performance supplement, including sustained-release nootropic capsules for men. IMSLEEPX addresses nighttime recovery as a sleep recovery supplement, while IMSTRONGX is positioned as a testosterone support supplement supporting men’s hormonal health.<\/p>\n

Together, the brands allow pharmacy and retail partners to address multiple areas of men’s sexual health OTC, cognitive wellness, sleep, performance and hormonal support through one portfolio.<\/p>\n

The commercial rollout also opens the company’s men’s health distribution partnership initiative to new regional and international partners. QuadroPharma is seeking relationships with organizations operating as a pharmacy nutraceutical partner, OTC men’s health distributor, men’s wellness retail partner or national distributor men’s health provider.<\/p>\n

The company is also accepting discussions with clinics and organizations interested in a pharmacy partnership program, as well as operators seeking a men’s health e-commerce brand for online and direct-to-consumer channels.<\/p>\n

“The opportunity for pharmacy, clinic, and e-commerce partners is straightforward — five brands that speak to the five biggest unmet needs in men’s health, all under one roof, all backed by citations a pharmacist would be comfortable recommending. We’re not asking partners to take a leap of faith. We’re handing them the evidence and letting it speak,” said Mukul Ayachit, Head of Partnerships, IMMANX Division.<\/p>\n

The global men’s health launch supports QuadroPharma’s expansion across the United States, Middle East, South Asia and additional international markets. Its company materials identify operations in Pennsylvania, Dubai and Mumbai, with IMMANX intended for pharmacy, clinic, e-commerce and national distribution channels.<\/p>\n

Partnership inquiries can be directed to info@quadropharma.com.<\/p>\n

About IMMANX<\/strong><\/p>\n

IMMANX is QuadroPharma’s dedicated men’s health division comprising IMALPHAX, IMBOLDX, IMFOCUSX, IMSLEEPX and IMSTRONGX. The portfolio addresses sexual confidence, performance, cognition, sleep and testosterone support through products developed under a shared manufacturing, testing and research framework.<\/p>\n

About QuadroPharma<\/strong><\/p>\n

QuadroPharma is a Pennsylvania-based consumer health company developing pharmaceutical-standard wellness products and brands. The company supports commercial operations and partnerships across the United States, the Middle East, South Asia and international markets.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> IMMANX by Quadro Pharma Inc
Contact Person:<\/strong> Aafreen
Email:<\/strong> Send Email<\/a>
Country:<\/strong> United States
Website:<\/strong> https:\/\/immanx.com\/<\/a><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Five specialist brands enter pharmacy, clinic, e-commerce and distribution channels with cGMP manufacturing and third-party testing NEW YORK, NY – September 4, 2026 – QuadroPharma, also operating as Quadro Pharma Inc,<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"_links":{"self":[{"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/posts\/548559"}],"collection":[{"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/comments?post=548559"}],"version-history":[{"count":0,"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/posts\/548559\/revisions"}],"wp:attachment":[{"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/media?parent=548559"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/categories?post=548559"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/tags?post=548559"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}